Cart
sales@molnova.com
A-196
CAS No. 1982372-88-2
A-196( SGC A-196 | SGC A 196 | SGC A196 )
Catalog No. M17412 CAS No. 1982372-88-2
A-196 is a potent and selective inhibitor of SUV420 h1 and SUV420 h2 with IC50 values of 0.025 and 0.144 μM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 329 | In Stock |
|
| 100MG | 498 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameA-196
-
NoteResearch use only, not for human use.
-
Brief DescriptionA-196 is a potent and selective inhibitor of SUV420 h1 and SUV420 h2 with IC50 values of 0.025 and 0.144 μM, respectively.
-
DescriptionSGC A-196 is a potent inhibitor of SUV420H1 (IC50 = 25 nM) and SUV420H2 (IC50 = 144 nM), a closely related pair of proteins which catalyze the di- and tri-methylation of H4K20.
-
In VitroWestern Blot Analysis Cell Line:U2OS cells Concentration:0 μM, 0.075 μM, 0.15 μM, 0.3 μM, 0.6 μM, 1.25 μM, 2.5 μM, 5 μM Incubation Time:48 hours Result:Increased in H4K20me1 and decreased in both H4K20me2 and H4K20me3.
-
In Vivo——
-
SynonymsSGC A-196 | SGC A 196 | SGC A196
-
PathwayOthers
-
TargetOther Targets
-
RecptorSUV420H1|SUV420H2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1982372-88-2
-
Formula Weight359.25
-
Molecular FormulaC18H16Cl2N4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 31 mg/mL; 86.29 mM
-
SMILESClc1cc3c(cc1Cl)c(nnc3NC2CCCC2)c4ccncc4
-
Chemical NameCyclopentyl-(6,7-dichloro-4-pyridin-4-yl-phthalazin-1-yl)-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bromberg KD,etal.The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.Nat Chem Biol. 2017 Mar;13(3):317-324.
molnova catalog
related products
-
Etifoxine hydrochlor...
Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.
-
WAY-325398
WAY-325398 is a furan derivatives. WAY-325398 inhibits osteoclast formation, inhibition rate is 14.11% at 10 μM.
-
Mal-PEG5-Boc
Mal-PEG5-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
